How it works
Sano makes research faster and lower cost by generating high-quality data sets and engaging patients before and between research phases.
Sano’s end-to-end precision medicine platform de-risks trials, enabling clinical operations teams to move 10x faster and reduce cost by 5x.
Working with exceptional life science companies and patient organisations
“ We were finding it challenging to engage a difficult patient population. Sano Genetics provided comprehensive recruitment services and delivered in a fraction of the time. We were delighted with the result. ”
Billy Boyle
CEO, Owlstone Medical
Sano's end-to-end precision medicine platform de-risks trials, enabling clinical operations teams to move 10x faster and reduce cost by 5x.
Protocol design and development
For consent, screening and engagement
Logistics, patient support, analysis and genetic counselling
Large network of genetically sequenced patients and recruitment partners
Hands-on clinical ops and genomics support
Seven years medical history retrieved on average
Sano makes research faster and lower cost by generating high-quality data sets and engaging patients before and between research phases.
83% of Sano users said they would be likely to recommend Sano to family and friends
70%of Sano users have been diagnosed with a chronic or rare genetic condition
>80%of participants say they would be disappointed if Sano didn't exist
Don't see the condition you're looking for?
We may still be able to support your project.
An online portal for participant engagement and long-term data collection. Customisable to your branding, and deployed securely to your cloud environment for maximum security.
Engage your community and generate revenue by connecting your community to precision medicine research opportunities. Customisable to your branding & securely deployed using industry-leading software.
Find out how we can support your research
Sano’s non-invasive at-home saliva samples are an effective, lower cost, and more patient-friendly method of collecting genetic data compared to at-site blood draws and do not require compromising on data quality.
Identification, screening and retention of patients with a genetic subtype of a neurodegenerative disease for the initial stages of a new treatment development program.
Rapid delivery of genetically qualified volunteers for a precision medicine clinical study in Alpha-1 antitrypsin deficiency.
We engaged with Sano to recruit participants for one of our studies. It was a particularly difficult patient population due to the rarity of the recruitment criteria. Their project team was very engaged, solution oriented and delivered in a fraction of the time we expected. We are delighted with the results.
We engaged with Sano to help recruit for real-world evidence study of people with Multiple Sclerosis. Sano’s partner network and patient-centric approach provided a boost of highly qualified and engaged participants when our other active recruitment channels were starting to saturate.
This study, run by Prof. Julian Gough of the MRC Laboratory of Molecular Biology, aimed to determine whether it is possible to predict phenotype from genotype, and whether a genetic link to COVID-19 risk can be detected, by using a bioinformatics approach based on the SUPERFAMILY resource.
Please fill out the information below to download this content.
Thegeneticspodcast
How can precision medicine techniques be used to develop potential new treatments for genetic Parkinson’s disease?